BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1364848)

  • 1. Regional heterogeneity in the contractile and potentiating effects of neuropeptide Y in rat isolated coronary arteries: modulatory action of the endothelium.
    Prieto D; Benedito S; Simonsen U; Nyborg NC
    Br J Pharmacol; 1991 Mar; 102(3):754-8. PubMed ID: 1364848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
    Prieto D; Simonsen U; Nyborg NC
    Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of noradrenaline on isolated proximal and distal coronary arteries of rat: selective release of endothelium-derived relaxing factor in proximal arteries.
    Nyborg NC
    Br J Pharmacol; 1990 Jul; 100(3):552-6. PubMed ID: 1975207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
    Andriantsitohaina R; Stoclet JC
    Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous involvement of endothelium in calcitonin gene-related peptide-induced relaxation in coronary arteries from rat.
    Prieto D; Benedito S; Nyborg NC
    Br J Pharmacol; 1991 Jul; 103(3):1764-8. PubMed ID: 1718522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxytryptamine does not release endothelium-derived relaxing factor in rat isolated coronary arteries.
    Nyborg NC; Mikkelsen EO
    Eur J Pharmacol; 1990 Sep; 186(2-3):295-300. PubMed ID: 2289529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-independent potentiating effects of neuropeptide Y in the rat tail artery.
    Small DL; Bolzon BJ; Cheung DW
    Eur J Pharmacol; 1992 Jan; 210(2):131-6. PubMed ID: 1318205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endothelium on the effects of neuropeptide Y in mesenteric resistance arteries of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Andriantsitohaina R; Stoclet JC; Bukoski RD
    J Pharmacol Exp Ther; 1991 Apr; 257(1):276-81. PubMed ID: 2019991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
    Corr L; Burnstock G; Poole-Wilson P
    Peptides; 1993; 14(2):359-64. PubMed ID: 8483814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery.
    Bjenning C; Holmgren S; Farrell AP
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H661-5. PubMed ID: 8368368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y potentiates contraction and inhibits relaxation of rabbit coronary arteries.
    Han C; Abel PW
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):675-81. PubMed ID: 2442533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.
    Prieto D; García-Sacristán A; Simonsen U
    Regul Pept; 1998 Sep; 75-76():155-60. PubMed ID: 9802404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
    Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
    Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of the neuropeptide Y (NPY) contractile and relaxing receptors in horse penile small arteries.
    Prieto D; Arcos LR; Martínez P; Benedito S; García-Sacristán A; Hernández M
    Br J Pharmacol; 2004 Dec; 143(8):976-86. PubMed ID: 15557288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries.
    Bottrill FE; Douglas SA; Hiley CR; White R
    Br J Pharmacol; 2000 Aug; 130(8):1865-70. PubMed ID: 10952676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the depressant effect of the endothelium on contractions of rabbit isolated basilar artery to 5-hydroxytryptamine.
    Trezise DJ; Drew GM; Weston AH
    Br J Pharmacol; 1992 Jul; 106(3):587-92. PubMed ID: 1504743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished contractile responses to neuropeptide Y of arteries from diabetic rabbits.
    Andersson D; Brunkwall J; Bergqvist D; Edvinsson L
    J Auton Nerv Syst; 1992 Mar; 37(3):215-22. PubMed ID: 1587998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.